Houston, TX – October 6, 2020 – Tienovix, LLC (“Tienovix”), an advanced Augmented Reality (“AR”) and Artificial Intelligence (“AI”) company that is reshaping industries with its unique human-machine interface, announced today the U. S. Patent and Trademark Office has issued a second patent, U.S. Patent No. 10,796,605, for its proprietary AR technology. This patent integrates our proprietary AR technology to all machines and devices expanding the company’s patent coverage outside the original field of medical technology as the company continues to innovate in the AR and AI fields. Additional AR-related patent applications are pending, and the company anticipates further expansion of its intellectual property portfolio from its ongoing R&D investments.
Tienovix is a worldwide leader in space-age mixed-reality and AI technology. Tienovix is developing a world-class intellectual property portfolio to protect and market its proprietary technology and brands. Tienovix is actively pursuing US and international patent and trademark protection for its innovative products and ideas. Well beyond the state-of-the-art, Tienovix has developed a portfolio of patent-pending technology, including AR systems that are capable of interactively guiding a remote user in performing various tasks.
For further inquiries, please contact:
Ramy Danial | Chief Executive Officer 1331 Gemini Ave. STE 315 | Houston, TX 77058 +1 281.928.8428 | firstname.lastname@example.org | www.tienovix.com